Erika Iervasi
Genoa, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Beyond translation: systematic insight of the multifaceted roles of GARS1 in cellular biology and disease.
Journal: Cell cycle (Georgetown, Tex.)
Published: December 15, 2025
Antiprotozoal Activity of Highly Substituted Pyrazole and Pyrimidine Derivatives.
Journal: ChemMedChem
Published: February 24, 2025
Novel tetrasubstituted 5-Arylamino pyrazoles able to interfere with angiogenesis and Ca2+ mobilization.
Journal: European journal of medicinal chemistry
Published: May 22, 2024
A Proteomics Approach Identifies RREB1 as a Crucial Molecular Target of Imidazo-Pyrazole Treatment in SKMEL-28 Melanoma Cells.
Journal: International journal of molecular sciences
Published: April 30, 2024
Investigations of Antioxidant and Anti-Cancer Activities of 5-Aminopyrazole Derivatives.
Journal: Molecules (Basel, Switzerland)
Published: April 04, 2024
Structure-Activity Relationship Studies on Highly Functionalized Pyrazole Hydrazones and Amides as Antiproliferative and Antioxidant Agents.
Journal: International journal of molecular sciences
Published: March 29, 2024
Anticancer Effects of the Novel Pyrazolyl-Urea GeGe-3.
Journal: International journal of molecular sciences
Published: March 21, 2024
Cyclic diacyl thioureas enhance activity of corrector Lumacaftor on F508del-CFTR.
Journal: ChemMedChem
Published: July 26, 2023
Fraisinib: a calixpyrrole derivative reducing A549 cell-derived NSCLC tumor in vivo acts as a ligand of the glycine-tRNA synthase, a new molecular target in oncology.
Journal: Frontiers in pharmacology
Published: July 13, 2023
Novel 5-aminopyrazoles endowed with anti-angiogenetic properties: Design, synthesis and biological evaluation.
Journal: European journal of medicinal chemistry
Published: May 19, 2023
Last Updated: 09/26/2026